Running throughout the fiercely competitive sectors of immuno-oncology and biotechnology, Agenus differentiates itself via a deep commitment to scientific innovation and specialized excellence. The corporate’s strategy displays a measured stability amongst revolutionary research and methodical clinical analysis, thus establishing a reputation cre